The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 11, 2018
Filed:
Dec. 04, 2015
Applicant:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Thomas H. Graham, Scotch Plains, NJ (US);
Mark W. Embrey, Harleysville, PA (US);
Abbas Walji, Lansdale, PA (US);
Sherman T. Waddell, Westfield, NJ (US);
Assignee:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); C07D 498/14 (2006.01); A61K 45/06 (2006.01); A61K 31/427 (2006.01); A61K 31/4402 (2006.01); A61K 31/47 (2006.01); A61K 31/505 (2006.01); A61K 31/513 (2006.01); A61K 31/52 (2006.01); A61K 31/5365 (2006.01); A61K 31/55 (2006.01); A61K 31/635 (2006.01); A61K 31/675 (2006.01); A61K 31/7072 (2006.01); C07D 471/04 (2006.01); C07D 491/20 (2006.01); A61K 31/553 (2006.01);
U.S. Cl.
CPC ...
C07D 498/14 (2013.01); A61K 31/427 (2013.01); A61K 31/4402 (2013.01); A61K 31/47 (2013.01); A61K 31/4985 (2013.01); A61K 31/505 (2013.01); A61K 31/513 (2013.01); A61K 31/52 (2013.01); A61K 31/5365 (2013.01); A61K 31/55 (2013.01); A61K 31/553 (2013.01); A61K 31/635 (2013.01); A61K 31/675 (2013.01); A61K 31/7072 (2013.01); A61K 45/06 (2013.01); C07D 471/04 (2013.01); C07D 491/20 (2013.01);
Abstract
The present invention relates to Spirocyclic Heterocycle Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, B, X, R, R, Rand Rare as defined herein. The present invention also relates to compositions comprising at least one Spirocyclic Heterocycle Compound, and methods of using the Spirocyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.